Figure 4 | Signal Transduction and Targeted Therapy

Figure 4

From: Transferrin protects against Parkinsonian neurotoxicity and is deficient in Parkinson’s substantia nigra

Figure 4

Chronic Tf supplementation decreases hemoglobin. C57/Bl6 male mice were administered apo-Tf (n=9; 30 mg kg−1; subcutaneously) every third day for 21 days and compared with controls (n=9). Blood was collected and hematology performed. HCT, hematocrit; MCV, mean corpuscular volume; MCH, mean corpuscular hemoglobin; MCHC, mean corpuscular hemoglobin concentration. Data are means±s.e.m. **P<0.01.

Back to article page